ClinicalTrials.gg
Status unknownNCT01785355PAROHEMUpdated Jul 23, 2019

The Impact Of Periodontal Disease Treatment On The General Health Status In Chronic Haemodialyzed Patients

An observational study in Periodontal Disease and Chronic Kidney Disease, sponsored by Anemia Working Group Romania. Status unknown at 1 site in Romania. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2019-07-23.

Sponsored by Anemia Working Group Romania · Observational

How we know

The sponsor has not verified this record recently (last verified Jul 2019), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
18 Years to 85 Years
Sex
All
01

Study summary

Several studies revealed a direct relationship between the severity of periodontal inflammation and CRP (NHANES III, Dumitriu HT et al, 1998). In patients without any other source of inflammation but PDD, proper dental treatment of the disease decreased CRP to normal levels (Dumitriu H.T. et al., 1998; D'Aiuto F. et al, 2004; Borawski J. et al., 2007) Moreover, a direct link between high levels of CRP and atherosclerotic complications has been found in studies conducted both in general population (Ridker PM, et al., 1998; Koenig W, et al., 1999) and in HD subjects (Westhuyzen J, et al., 2000; Iseki K., et al., 1999; Zimmermann J, et al. 1998).

Read the detailed description

Patients will be recruited according to eligibility criteria. Initial oral and general status will be evaluated and recorded. The evaluated parameters are listed at the study description section. Also, quality of life will be assessed by using the SF-36 and OHIP-14 questionnaires.

Patients will undergo a series of dental interventions with the final scope of eliminating all oral inflammation. Participants will also be instructed regarding correct oral hygiene habits.

Following dental and periodontal treatments, the oral and general status will be reassessed and the obtained dat analysed.

02

Conditions studied

  • Periodontal Disease
  • Chronic Kidney Disease

Keywords

  • periodontal disease
  • CKD
  • nutrition
  • inflammation
  • anemia response to ESA
  • quality of life
  • hemodialysis
03

In context

Periodontal Diseases

871 studies on the registry are indexed under Periodontal Diseases; 191 are open to participants now.

This study's planned enrollment of 30 is below the median of 100 across 304 observational studies indexed under Periodontal Diseases.

Browse Periodontal Diseases studies →

Lead sponsor

Anemia Working Group Romania is the lead sponsor of 9 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Haemodialyzed patients with Periodontal Disease

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Hemodialyzed patients with periodontal disease

Exclusion criteria

Exclusion Criteria:

  • , Diabetes
  • Patient refusal to participate
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Dental treatment

    Assessment of the clinical state of the patient. Professional prophylaxis and removal of calculus. Extraction of hopeless teeth.Education of patient for oral hygiene. Periodic reevaluation.

    Other: Dental treatment

Interventions

  • OtherDental treatment

    1. The preliminary stage deals with: * assessment of the clinical state of the patient by completing a detailed dental and periodontal chart * education of the patient regarding correct oral hygiene habits; 2. Phase I Therapy: * plaque control : removal of dental plaque, calculus and root planning; antimicrobial therapy (local or systemic) * evaluation of response to the treatment 3. Phase II Therapy - surgical phase: * extraction of hopeless teeth * evaluation of the surgical results. 4. Maintenance phase: * periodic reevaluation of plaque and calculus and of periodontal conditions.

06

What researchers measure

Primary outcomes

  1. Modification of nutritional status

    SGA, whole body bioimpedance, biochemical parameters (serum albumin, predialysis serum urea, serum creatinine, serum phosphates)

    Time frame: 6 months

Secondary outcomes

  1. Modification of inflammatory status

    C Reactive Protein

    Time frame: 6 months

Other outcomes

  1. Modification of periodontal disease index

    Modification of periodontal disease index assessed by the CAL, PPD, bleeding index

    Time frame: 3 months

  2. Modification of the quality of life, as assessed by SF-36 and OHIP-14

    Modification of the quality of life, as assessed by SF-36 and OHIP-14

    Time frame: 6 months

  3. Modification of anaemia response to epoetin

    Modification of anaemia response to epoetin, as assessed by the ERI and by the cumulative ESAs dose

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • CMI "Dr Slusanschi Oana"
    Bucharest, Romania
    Recruiting
    • Oana Slusanschi, DMD · Contactoanciu@yahoo.com · +40722266279
    • Oana Slusanschi, DMD · Principal investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2012 (actual). Primary completion is estimated for Sep 2021, 108 months after the start.

Of 79 non-industry observational studies under Periodontal Diseases, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 108 months is above that.

Counting every sponsor, half of 83 studies reached it within 13 months; a quarter within 7 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 29, 2013
First posted
Feb 7, 2013
StartActual
Sep 2012
Primary completionEst.
Sep 2021
CompletionEst.
Jun 2022
Last update
Jul 23, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 23, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01785355
Lead sponsor
Anemia Working Group Romania
Responsible party
Oana Slusanschi (DMD, Anemia Working Group Romania) — Principal investigator
First posted
Feb 7, 2013
Start date
Sep 2012
Primary completion
Sep 2021 (estimated)
Completion
Jun 2022 (estimated)
Last update
Jul 23, 2019

Study contacts

Oana Slusanschi, DMD
Contact
oanciu@yahoo.com
+40722266279
Liliana Garneata, MD
Contact
lilianagarna@yahoo.com
+40722619358
Oana Slusanschi, DMD
principal investigator · University of Medicine and Pharmacy Bucharest

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion